American Society for Radiation Oncology

SBRT Reduces Rectal Toxicity in Intermediate-Risk Prostate Cancer Trial

September 4, 2026

Results from the phase 3 NRG-GU005 trial, presented at the 2025 American Society for Radiation Oncology Annual Meeting, show that stereotactic body radiation therapy (SBRT)…

SBRT Improves Bowel Quality of Life in Prostate Cancer Trial

August 25, 2026

Results from the large-scale NRG-GU005 clinical trial show that stereotactic body radiation therapy for intermediate-risk prostate cancer significantly improves bowel quality of…

Sections

Editorial

Legal